Syros Pharmaceuticals, Inc.
They are pioneering the understanding of the non-coding region of the genome to advance a new wave of medicines that control expression of genes.
Last Closing Price
January 31, 2018
J.P. Morgan, Cowen, Piper Jaffray
To view the prospectus for Syros Pharmaceuticals, Inc., or any offering listed on ClickIPO,
download the ClickIPO app...
or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC 8601 N Scottsdale Rd, Suite 335, Scottsdale, AZ 85253